PAR
Click for more information
0.00% 28.0¢ paradigm biopharmaceuticals limited..

Ann: 2023 Annual Report and Appendix 4E, page-10

  1. PZ99
    278 Posts.
    lightbulb Created with Sketch. 107
    clock Created with Sketch.
    25/08/23
    17:35
    Post #: 69555608
    I’m happy to be corrected, but as I understand it Cartrophen is pretty much identical to what we have, although not approved for human use. I doubt therefore that they’ll be any revenue at all from treating pooches.
    PAR Price at posting: 71.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 12  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
28.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $97.94M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 2000 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.5¢ 1200 1
View Market Depth
Last trade - 09.50am 03/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.